Predicted extracapsular invasion of hilar lymph node metastasis by fusion positron emission tomography/computed tomography in patients with lung cancer

Makino,Takashi; Hata,Yoshinobu; Otsuka,Hajime; Koezuka,Satoshi; Isobe,Kazutoshi; Tochigi,Nobumi; Shiraga,Nobuyuki; Shibuya,Kazutoshi; Homma,Sakae; Iyoda,Akira

doi:10.3892/mco.2015.596

Predicted extracapsular invasion of hilar lymph node metastasis by fusion positron emission tomography/computed tomography in patients with lung cancer

Authors:
- Takashi Makino
- Yoshinobu Hata
- Hajime Otsuka
- Satoshi Koezuka
- Kazutoshi Isobe
- Nobumi Tochigi
- Nobuyuki Shiraga
- Kazutoshi Shibuya
- Sakae Homma
- Akira Iyoda
View Affiliations

Affiliations: Division of Chest Surgery, Toho University School of Medicine, Tokyo 143‑8541, Japan, Division of Respiratory Medicine, Toho University School of Medicine, Tokyo 143‑8541, Japan, Department of Surgical Pathology, Toho University School of Medicine, Tokyo 143‑8541, Japan, Department of Radiology, Toho University School of Medicine, Tokyo 143‑8541, Japan
Published online on: July 1, 2015 https://doi.org/10.3892/mco.2015.596
Pages: 1035-1040

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intraoperative detection of hilar lymph node metastasis, particularly with extracapsular invasion, may affect the surgical procedure in patients with lung cancer, as the preoperative estimation of hilar lymph node metastasis is unsatisfactory. The aim of this study was to investigate whether fusion positron emission tomography/computed tomography (PET/CT) is able to predict extracapsular invasion of hilar lymph node metastasis. Between April, 2007 and April, 2013, 509 patients with primary lung cancer underwent surgical resection at our institution, among whom 28 patients exhibiting hilar lymph node metastasis (at stations 10 and 11) were enrolled in this study. A maximum lymph node standardized uptake value of >2.5 in PET scans was interpreted as positive. A total of 17 patients had positive preoperative PET/CT findings in their hilar lymph nodes, while the remaining 11 had negative findings. With regard to extracapsular nodal invasion, the PET/CT findings (p=0.0005) and the histological findings (squamous cell carcinoma, p=0.05) were found to be significant predictors in the univariate analysis. In the multivariate analysis, the PET/CT findings were the only independent predictor (p=0.0004). The requirement for extensive pulmonary resection (sleeve lobectomy, bilobectomy or pneumonectomy) was significantly more frequent in the patient group with positive compared with the group with negative PET/CT findings (76 vs. 9%, respectively, p=0.01). Therefore, the PET/CT findings in the hilar lymph nodes were useful for the prediction of extracapsular invasion and, consequently, for the estimation of possible extensive pulmonary resection.

View Figures

View References

1	Mountain CF: Revisions in the international system for staging lung cancer. Chest. 111:1710–1717. 1997. View Article : Google Scholar : PubMed/NCBI
2	Rusch VW, Crowley J, Giroux DJ, Goldstraw P, Im JG, Tsuboi M, Tsuchiya R and Vansteenkiste JInternational Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions: The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2:603–612. 2007. View Article : Google Scholar : PubMed/NCBI
3	Watanabe S, Asamura H, Suzuki K and Tsuchiya R: Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Ann Thorac Surg. 79:1682–1685. 2005. View Article : Google Scholar : PubMed/NCBI
4	Hishida T, Yoshida J, Nishimura M, Nishiwaki Y and Nagai K: Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer. Thorax. 63:526–531. 2008. View Article : Google Scholar : PubMed/NCBI
5	Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T and Oh S: The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Eur J Cardiothorac Surg. 44:83–87. 2013. View Article : Google Scholar : PubMed/NCBI
6	Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK and Weder W: Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 202:441–446. 1997. View Article : Google Scholar : PubMed/NCBI
7	Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL and Mortelmans LALeuven Lung Cancer Group: Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: A prospective analysis of 50 cases. Chest. 112:1480–1486. 1997. View Article : Google Scholar : PubMed/NCBI
8	Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, Nuyts JL, Maes FP and Bogaert JG: FDG-PET scan in potentially operable non-small cell lung cancer: Do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med. 25:1495–1501. 1998. View Article : Google Scholar : PubMed/NCBI
9	Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ and Kirsch CM: ¹⁸F-FDG PET for mediastinal staging of lung cancer: Which SUV threshold makes sense? J Nucl Med. 48:1761–1766. 2007. View Article : Google Scholar : PubMed/NCBI
10	Carrillo SA, Daniel VC, Hall N, Hitchcock CL, Ross P Jr and Kassis ES: Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer. Ann Thorac Surg. 93:1621–1624. 2012. View Article : Google Scholar : PubMed/NCBI
11	Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R and Goldstraw PMembers of IASLC Staging Committee: The IASLC Lung Cancer Staging Project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 4:568–577. 2009. View Article : Google Scholar : PubMed/NCBI
12	Detterbeck FC, Boffa DJ and Tanoue LT: The new lung cancer staging system. Chest. 136:260–271. 2009. View Article : Google Scholar : PubMed/NCBI
13	Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, Mortelmans LA and Demedts MGLeuven Lung Cancer Group: Prognostic importance of the standardized uptake value on ¹⁸F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. J Clin Oncol. 17:3201–3206. 1999.PubMed/NCBI
14	Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, Ravn J, Clementsen P, Høgholm A, Larsen K, et al: Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 361:32–39. 2009. View Article : Google Scholar : PubMed/NCBI
15	Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E and Detterbeck FAmerican College of Chest Physicians: Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 132 (Suppl 3):178S–201S. 2007. View Article : Google Scholar : PubMed/NCBI
16	Ernst A, Eberhardt R, Krasnik M and Herth FJ: Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer. J Thorac Oncol. 4:947–950. 2009. View Article : Google Scholar : PubMed/NCBI
17	Shin S, Kim HK, Choi YS, Kim K, Kim J and Shim YM: Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer. Ann Thorac Surg. 96:969–975; discussion. 975–976. 2013. View Article : Google Scholar : PubMed/NCBI
18	Moreno AC, Morgensztern D, Boffa DJ, Decker RH, Yu JB, Detterbeck FC, Wang Z, Rose MG and Kim AW: Treating locally advanced disease: An analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base. Ann Thorac Surg. 97:1149–1155. 2014. View Article : Google Scholar : PubMed/NCBI
19	Watanabe S, Asamura H, Suzuki K and Tsuchiya R: Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg. 78:999–1002; discussion. 1002–1003. 2004. View Article : Google Scholar : PubMed/NCBI